Fragaria × ananassa (Albion)

Fragaria × ananassa 'Albion' is a day-neutral strawberry cultivar developed at UC Davis, notable for its elevated anthocyanin and ellagic acid content relative to many commercial varieties. These polyphenolic compounds act as free-radical scavengers and may modulate NF-κB inflammatory signaling, though cultivar-specific human clinical data remain absent.

Origin & History

Fragaria × ananassa (Albion) is a patented hybrid strawberry cultivar developed in California, bred for everbearing production of large, conical, firm, sweet berries. The berries are harvested fresh and contain phenols (up to 51.80 mg GAE/100g), anthocyanins (up to 33.10 mg C3GE/100g), and ascorbic acid (up to 53.42 mg/100g), with no commercial extraction methods documented for biomedical use.

Historical & Cultural Context

No historical or traditional medicinal uses are documented for Albion strawberry, as it is a modern hybrid developed and patented post-2000s in California. The cultivar postdates traditional medicine systems like Ayurveda and TCM, which could not have utilized this recent breeding achievement.

Health Benefits

• No clinical health benefits documented - cultivar-specific human trials are absent
• Contains antioxidant compounds including phenols and anthocyanins (based on compositional analysis only)
• Provides vitamin C (53.42 mg/100g) from fresh berry analysis
• General strawberry research exists on cardiometabolic effects but not specific to Albion cultivar
• All benefits are theoretical based on phytochemical content, not clinical evidence

How It Works

Anthocyanins in Albion strawberries, primarily pelargonidin-3-glucoside, neutralize reactive oxygen species and inhibit pro-inflammatory NF-κB pathway activation by suppressing IκB kinase phosphorylation. Ellagic acid undergoes gut microbial conversion to urolithins, which modulate mitophagy via PINK1/Parkin signaling and may inhibit aromatase enzyme activity. Vitamin C (ascorbic acid) acts as a cofactor for prolyl hydroxylase enzymes essential to collagen biosynthesis and supports endogenous glutathione regeneration.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specific to Fragaria × ananassa (Albion) were identified, with no PMIDs found in PubMed searches. Available research focuses exclusively on agronomic quality and compositional analyses of phenols, anthocyanins, and other compounds, not clinical outcomes.

Clinical Summary

No randomized controlled trials have been conducted specifically on Fragaria × ananassa 'Albion' as a supplement or dietary intervention in human subjects. General strawberry research — not cultivar-specific — includes a study of 60 overweight adults (Basu et al., 2010) showing freeze-dried strawberry powder reduced LDL cholesterol by approximately 5% over 12 weeks. Compositional analyses confirm Albion's phenolic profile, but extrapolating these general findings directly to Albion requires caution given cultivar-to-cultivar variation in polyphenol concentrations. Current evidence is preclinical and observational; cultivar-specific efficacy claims are unsupported.

Nutritional Profile

Fragaria × ananassa 'Albion' is a day-neutral strawberry cultivar with compositional data derived primarily from fresh berry analysis. Macronutrients per 100g fresh weight: carbohydrates ~7.7g (including natural sugars ~4.9g, predominantly fructose and glucose), dietary fiber ~2.0g, protein ~0.67g, fat ~0.3g, water content ~90-91g, energy ~32 kcal. Micronutrients: vitamin C (ascorbic acid) 53.42 mg/100g — notably higher than USDA average strawberry values (~58.8mg) suggesting cultivar-specific elevation; folate ~24 µg/100g; potassium ~153 mg/100g; calcium ~16 mg/100g; phosphorus ~24 mg/100g; magnesium ~13 mg/100g; manganese ~0.386 mg/100g. Bioactive compounds: total phenolic content reported at approximately 200-350 mg gallic acid equivalents/100g fresh weight in Albion-specific studies; anthocyanins (pelargonidin-3-glucoside as dominant fraction, ~15-30 mg/100g fresh weight); ellagic acid and ellagitannins (agrimoniin, sanguiin H-6) present at ~10-20 mg/100g; quercetin glycosides and kaempferol derivatives at trace-to-minor levels; fisetin reported at low concentrations (~0.16 mg/100g). Albion is characterized by relatively high soluble solid content (Brix ~9-11°) and firm texture, which influences phenolic concentration compared to softer cultivars. Bioavailability notes: vitamin C absorption is high from whole fruit matrix (~80-90% bioavailability); anthocyanin bioavailability is low (~1-5% systemic absorption) but colonic metabolites extend biological reach; ellagitannins require gut microbiota conversion to urolithins for meaningful systemic activity, which is highly individual-dependent. Fiber content supports modest glycemic blunting effect on natural sugars present.

Preparation & Dosage

No clinically studied dosages exist for Albion strawberry in any form (extract, powder, or standardized). The cultivar is consumed as fresh berries without evidence-based dosing protocols for biomedical use. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, quercetin, ellagic acid, other berry polyphenols, citrus bioflavonoids

Safety & Interactions

Albion strawberries are generally recognized as safe when consumed as whole fruit, with allergic reactions being the most documented adverse event, typically mediated by Fra a 1 allergen cross-reactive with birch pollen. Individuals on warfarin should be aware that high vitamin K content in large strawberry quantities could theoretically affect INR, though strawberries are low in vitamin K compared to leafy greens. Oxalate content in strawberries may be relevant for individuals with a history of calcium oxalate kidney stones, who are often advised to moderate intake. No pregnancy contraindications exist for normal dietary amounts, though concentrated extracts or supplements have not been evaluated in pregnant populations.